Cite
HARVARD Citation
Robinson, P. et al. (2022). Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study. ACR open rheumatology. 4 (9), pp. 794-801. [Online].